Hangzhou Normal University, Hangzhou, China.
Hunan University of Chinese Medicine, Changsha, China.
J Diabetes Investig. 2022 Mar;13(3):543-551. doi: 10.1111/jdi.13685. Epub 2021 Oct 21.
Epidemiological studies suggested that the association between the visceral adiposity index (VAI) and the risk of prediabetes is inconsistent. Whether VAI is a useful predictor of prediabetes remains unclear. Up until April 2021, there had been no systematic review on this topic. In this meta-analysis, the available observational epidemiological evidence was synthesized to identify the association between VAI and prediabetes risk.
PubMed, EMBASE, and Cochrane databases in any language were searched systematically from the earliest available online indexing year to April 2021 for relevant observational studies published on the association between VAI and the risk of prediabetes. A random effects model was used to combine quantitatively the odds ratios (ORs) and 95% confidence intervals (CIs).
Ten relevant studies (2 cohort study, 2 case-control studies, and 6 cross-sectional studies) involving 112,603 participants were identified. Compared with the highest VAI, the lowest level of VAI was associated with an increased risk of prediabetes. The pooled OR of VAI for prediabetes was 1.68 (95% CI: 1.44-1.96), with significant heterogeneity across the included studies (P = 0.000, I = 91.4%). Exclusion of any single study did not materially alter the combined risk estimate.
Integrated epidemiological evidence supports the hypothesis that VAI is a lipid combined anthropometric index and may be a risk factor for prediabetes. VAI may be related to a high risk of prediabetes. However, it should be noted that the included studies have a publication bias and there was significant heterogeneity between our pooled estimate.
流行病学研究表明,内脏脂肪指数(VAI)与糖尿病前期风险之间的关联并不一致。VAI 是否是糖尿病前期的有用预测指标尚不清楚。截至 2021 年 4 月,尚无关于该主题的系统评价。在这项荟萃分析中,综合了现有的观察性流行病学证据,以确定 VAI 与糖尿病前期风险之间的关联。
系统检索了所有语言的 PubMed、EMBASE 和 Cochrane 数据库,从最早可在线获取的索引年份到 2021 年 4 月,以获取有关 VAI 与糖尿病前期风险之间关联的观察性研究。使用随机效应模型对比值比(OR)和 95%置信区间(CI)进行定量合并。
确定了 10 项相关研究(2 项队列研究、2 项病例对照研究和 6 项横断面研究),涉及 112603 名参与者。与 VAI 最高水平相比,VAI 最低水平与糖尿病前期风险增加相关。VAI 发生糖尿病前期的汇总 OR 为 1.68(95%CI:1.44-1.96),纳入研究之间存在显著异质性(P = 0.000,I 2 = 91.4%)。排除任何一项单独的研究都不会显著改变合并风险估计。
综合的流行病学证据支持 VAI 是一种脂质综合人体测量指数的假说,并且可能是糖尿病前期的危险因素。VAI 可能与糖尿病前期的高风险有关。但是,应该注意的是,纳入的研究存在发表偏倚,并且我们的汇总估计值之间存在显著的异质性。